Ketamine intravenous (NRx Pharmaceuticals)

N/A

Report date: 2025/10/24 17:59:53

Base Information

Drug NameKetamine intravenous (NRx Pharmaceuticals)
Drug Alias NameHTX-100 IV ketamineNRX-100HTX-100
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsSuicidal Ideation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesNRx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNRx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSuicidal Ideation
Inactive IndicationsN/A

Other Information

ATC CodeN01AX03
Related LinksN/A